Home
About
FAQ
History (1)
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.
Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 2004 Mar 15; 64(6):2070-5.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Cell Division
Enzyme Inhibitors
Humans
Lactones
Male
Mice
Mice, Nude
Prostatic Neoplasms
Tumor Cells, Cultured
authors with profiles
Steven J. Kridel PhD